Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-11

Clinical Trial Update: Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating different multivitamin dosage regimens to prevent adverse pregnancy outcomes in HIV-positive women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Multivitamin supplements (multivitamin)

Snippet

Sponsor: Harvard School of Public Health (HSPH) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED